Literature DB >> 11003279

Radiolabeled leucocyte imaging in diffuse granulomatous involvement of the meninges in Wegener's granulomatosis: scintigraphic findings and their role in monitoring treatment response to specific immunotherapy (humanized monoclonal antilymphocyte antibodies).

J M Murphy1, K K Balan, A Toms, B Gomez-Anson, M Lockwood.   

Abstract

BACKGROUND AND
PURPOSE: Diffuse involvement of the meninges by remote granulomas in Wegener's granulomatosis is rare. This study reports the radiolabeled leucocyte imaging findings in five such patients. The diagnosis was made by MR imaging in five patients and confirmed in four by findings at meningeal biopsy. The potential role of serial radiolabeled leucocyte examinations in assessing treatment response is discussed.
METHODS: Three of the five patients underwent whole-body planar 111In-labeled leucocyte imaging. Two of these patients had serial imaging and one had, in addition, a 99mTc-HMPAO-labeled leucocyte single-photon emission CT brain examination. Two of the five patients had whole-body planar 99mTc-HMPAO-labeled leucocyte imaging. Of these, one patient had serial imaging. The radiolabeled leucocyte imaging findings were correlated with MR findings and with the patients' clinical course.
RESULTS: In four patients there was a midline linear area of increased tracer uptake in the brain, and in one of these, tracer uptake also extended laterally over the brain convexity. In two patients linear tracer uptake extended in an inferolateral direction from the midline. These abnormalities correlated with meningeal thickening in the falx, over the brain convexity, and in the tentorium cerebelli on MR images. Serial imaging in three patients revealed a reduction or disappearance in tracer uptake after treatment with anti-CD52, which correlated with clinical improvement.
CONCLUSION: In patients with Wegener's granulomatosis, abnormal uptake corresponding to meningeal thickening can be seen on planar radiolabeled leucocyte images. Leucocyte imaging may be useful for monitoring treatment response.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11003279      PMCID: PMC7974063     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  21 in total

1.  The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis.

Authors:  R Y Leavitt; A S Fauci; D A Bloch; B A Michel; G G Hunder; W P Arend; L H Calabrese; J F Fries; J T Lie; R W Lightfoot
Journal:  Arthritis Rheum       Date:  1990-08

2.  High resolution single photon emission computed tomography of the brain in Wegener's granulomatosis.

Authors:  J Marienhagen; A Geissler; B Lang
Journal:  J Rheumatol       Date:  1996-10       Impact factor: 4.666

3.  The spectrum of neurologic involvement in Wegener's granulomatosis.

Authors:  H Nishino; F A Rubino; J E Parisi
Journal:  Neurology       Date:  1993-07       Impact factor: 9.910

4.  Intracranial Wegener's granulomatosis.

Authors:  L M Weinberger; M L Cohen; B F Remler; M H Naheedy; R J Leigh
Journal:  Neurology       Date:  1993-09       Impact factor: 9.910

5.  Primary intracranial lymphoma of the dura.

Authors:  F K Jazy; W M Shehata; J M Tew; R L Meyer; H H Boss
Journal:  Arch Neurol       Date:  1980-08

6.  Hypertrophic cranial pachymeningitis: assessment with CT and MR imaging.

Authors:  N Martin; C Masson; D Henin; D Mompoint; C Marsault; H Nahum
Journal:  AJNR Am J Neuroradiol       Date:  1989 May-Jun       Impact factor: 3.825

7.  Sarcoidosis of the CNS: comparison of unenhanced and enhanced MR images.

Authors:  J L Sherman; B J Stern
Journal:  AJNR Am J Neuroradiol       Date:  1990 Sep-Oct       Impact factor: 3.825

8.  Wegener granulomatosis: an analysis of 158 patients.

Authors:  G S Hoffman; G S Kerr; R Y Leavitt; C W Hallahan; R S Lebovics; W D Travis; M Rottem; A S Fauci
Journal:  Ann Intern Med       Date:  1992-03-15       Impact factor: 25.391

Review 9.  Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years.

Authors:  A S Fauci; B F Haynes; P Katz; S M Wolff
Journal:  Ann Intern Med       Date:  1983-01       Impact factor: 25.391

10.  Management of systemic vasculitis: contribution of scintigraphic imaging to evaluation of disease activity and classification.

Authors:  H Reuter; E P Wraight; F J Qasim; C M Lockwood
Journal:  QJM       Date:  1995-07
View more
  1 in total

Review 1.  Nuclear imaging of neuroinflammation: a comprehensive review of [11C]PK11195 challengers.

Authors:  Fabien Chauveau; Hervé Boutin; Nadja Van Camp; Frédéric Dollé; Bertrand Tavitian
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-10-01       Impact factor: 9.236

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.